Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 29 August, 2019

HBK Investments LP

Form 8.3 - Allergan Plc

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1) HBK Investments L.P. on behalf of itself, its subadvisors and its managed funds
Company dealt in ALLERGAN PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) US $0.0001 Ordinary Shares
Date of dealing 28 August 2019
  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 100 (0.00%) 29,223 (0.00%)
(2) Derivatives (other than options) 5,500,000 (1.67%)
(3) Options and agreements to purchase/sell 37,200 (0.01%) 36,000 (0.01%)
Total 5,537,300 (1.68%) 65,223 (0.01%)
  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell
Total

Ap20

  1. DEALINGS (Note 4)

(a)      Purchases and sales


Purchase/sale

Number of relevant securities

Price per unit (Note 5)
  1. Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
Total Return Swap Increasing long position 5,130 USD 160.7048
  1. Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
  1. Exercising
Product name,
e.g. call option
Number of securities Exercise price per unit (Note 5)
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction
(Note 8)
Details Price per unit
(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

      None.

Is a Supplemental Form 8 attached? (Note 9)                                            YES

Date of disclosure 29 August 2019
Contact name Jonathan Brown
Telephone number +44 (0)20 7659 1906
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name,
e.g. call option
Written, or purchased Number of relevant securities to which the option or derivative relates Exercise price (Note 2) Type, e.g. American, European etc. Expiry date
Call Option Purchased 20,000 USD 135 American 17 Jan 2020
Call Option Purchased 17,200 USD 120 American 17 Jan 2020
Put Option Purchased 20,000 USD 130 American 17 Jan 2020
Put Option Purchased 16,000 USD 120 American 17 Jan 2020

Notes

  1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
  1. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.


a d v e r t i s e m e n t